Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,778 across all filing types
Latest filing 2016-03-30 Director's Dealing
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
DGAP-DD: Evotec AG english
Director's Dealing Classification · 100% confidence The document text explicitly contains the header "Directors’ Dealings" and details a transaction (Purchase of 20,000 shares) by a person in a managing body (Werner Lanthaler) of Evotec AG. This directly corresponds to the definition of Director's Dealing, which is classified under the code DIRS.
2016-03-30 English
Jahresfinanzbericht 2015
Annual Report Classification · 100% confidence The document is explicitly titled 'GESCHÄFTSBERICHT 2015' (Annual Report 2015) for Evotec AG. It contains a comprehensive table of contents covering the letter to shareholders, corporate governance, management reports, financial statements (Konzernabschluss), and audit opinions. It is a full-length annual report, not an announcement or summary, and provides detailed financial and operational data for the fiscal year 2015. FY 2015
2016-03-23 German
Evotec FY 2015: Excellent execution meets first-in-class innovation
Earnings Release Classification · 95% confidence The document is an official announcement from Evotec AG regarding its financial results for the fiscal year ended 31 December 2015. It contains key financial highlights, operational performance summaries, and guidance for the upcoming year. While it provides substantive financial data, it is structured as a press release (DGAP-News) rather than the full statutory Annual Report (10-K). According to the filing definitions, an initial announcement of periodical financial results containing key highlights is classified as an Earnings Release (ER). FY 2015
2016-03-22 English
Evotec spins off auto-immune disease company as 'Topas Therapeutics GmbH'
Regulatory Filings Classification · 100% confidence The document is a press release dated March 22, 2016, announcing the formation of a spin-off company, Topas Therapeutics GmbH, and detailing a Series A financing round involving several investors. It uses keywords like "DGAP-News," "Corporate," and discusses business structure changes and financing. This type of announcement, detailing corporate restructuring, financing activities, and strategic business updates, fits best under Capital/Financing Update (CAP) or potentially Regulatory Filings (RNS) if it were a general announcement. Since it explicitly details a financing round (Series A financing round of EUR 14 m) and the creation of a new entity, 'Capital/Financing Update' (CAP) is the most specific fit. It is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA).
2016-03-22 English
Präsentation FY 2015
Investor Presentation Classification · 95% confidence The document is titled 'Evotec FY 2015 & Outlook 2016' and contains detailed sections on 'Financial performance 2015', 'Outlook & Guidance 2016', 'EVT Execute', and 'EVT Innovate'. It presents historical financial data (FY 2015) alongside forward-looking guidance for the next year (2016). This structure, covering a full fiscal year's performance and future outlook, is characteristic of an Annual Report (10-K) or a comprehensive presentation summarizing the annual results. Since it is presented as a presentation deck (indicated by the agenda structure, slides, and focus on strategy/outlook), it is most likely an Investor Presentation (IP) summarizing the annual results, rather than the formal 10-K filing itself, or a standalone Earnings Release (ER) which is usually shorter and focuses only on the period results. Given the depth of strategy and pipeline review alongside financials, 'Investor Presentation' (IP) is the best fit.
2016-03-22 English
Evotec AG: Fiscal year 2015 results presentation on 22 March 2016
Report Publication Announcement Classification · 99% confidence The document is a press release dated March 15, 2016, announcing that Evotec AG will report its fiscal year 2015 financial results on March 22, 2016. It provides details for an upcoming conference call and webcast to discuss these results and present an outlook for 2016. This is not the actual financial report (10-K or IR), nor is it a transcript of the call (CT). It is an announcement about the publication of results and the associated investor event. Since it announces the release of financial results and provides details for the subsequent discussion/presentation, it most closely aligns with an Earnings Release (ER) which typically precedes or accompanies the full results, or potentially a Report Publication Announcement (RPA) if it were purely about the publication timing. However, because it explicitly states the company 'will report its financial results' and details the conference call to 'discuss the results,' classifying it as an Earnings Release (ER) is the most appropriate fit among the primary financial filing types, as ERs often serve as the initial announcement of period results.
2016-03-15 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.